This is a historical report — it no longer reflects this drug's current status. Current status: Anticipated Shortage. View this drug's full profile page →
JANUMET XR
MERCK CANADA INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of JANUMET XR in Canada?
A shortage of JANUMET XR 1000MG 100MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated August 20, 2026), but it has not started yet.
Why is JANUMET XR not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will JANUMET XR be available again?
The manufacturer's estimated resolution date is October 9, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
What this means
Does this mean the shortage is completely over everywhere?
It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.
What should I do?
If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.
DIN
02416808
Strength
1000MG 100MG
Dosage Form
TABLET (EXTENDED-RELEASE)
Route
ORAL
Active Ingredient
METFORMIN HYDROCHLORIDE SITAGLIPTIN
Tier
Unrated
Last Updated
2019-02-27
Reason for Shortage
Disruption of the manufacture of the drug.
Past Reports for This Drug
JANUMET XR has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from MERCK CANADA INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
40MG · DIN 00782327
10MG · DIN 02483513
15MG · DIN 02483521
20MG · DIN 02483548
100MG · DIN 02451816
50MG · DIN 02244265
70MG · DIN 02244266
DIN 02549891
DIN 02482592
200MG · DIN 02387174
0.05% · DIN 00688622
0.05% · DIN 00862975